Evercore ISI is adding Fortrea Holdings to the firm’s “Tactical Outperform” list ahead of Q2 EPS from the Healthcare Technology & Distribution group. Fortrea is likely to expand EBITDA margins by about 280 basis points year-over-year by YE24, says the analyst, who has an Outperform rating and $31 price target on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE:
- Fortrea Holdings launches AI Innovation Studio
- Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
- Fortrea Holdings Inc. Strategically Slashes Debt Burden
- Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
- Dollar Tree downgraded, Lululemon upgraded: Wall Street’s top analyst calls